Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Peter Impey

- PMLiVE

Alexion’s Soliris gets US approval for myasthenia gravis

New neurology indication could contribute $1.2bn to sales, says analysts

- PMLiVE

Gilead wins European approval for triple hep C combination Vosevi

The treatment brings together sofosbuvir, velpatasvir and voxilaprevir

Silence Therapeutics appoints Dr Annalisa Jenkins as non-executive chair

The Dimension Therapeutics CEO succeeds Dr Stephen Parker, who becomes a non-executive director

- PMLiVE

MC Services welcomes Dr Claudia Gutjahr-Loeser to its management team

She joins the PR firm from MorphoSys, where she was senior VP

- PMLiVE

Positive disruption in business intelligence

A drug launch strategy

- PMLiVE

Change in the pharma industry is inevitable

But successul change isn't

- PMLiVE

AZ gets US green light for new Bydureon formulation

Its latest injectable suspension proven to reduce blood sugar levels

Novartis Gehry Building

Alcon spin-out more likely but not imminent, says Novartis

A stand-alone company could offer “additional shareholder value”

- PMLiVE

TiGenix’s Crohn’s fistulas treatment wins orphan drug status

FDA designation follows positive trial results

- PMLiVE

Patient disengagement

Understanding the why

Incanthera appoints Laura Brogden as CFO

She joins from Summ.it

- PMLiVE

PharmaLex strengthens international team

Consultancy group appoints Adrian Pencak

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links